检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:庞建云[1,2] 刘肖[1,2] 申宝德[2,3] 沈成英[2] 连王权 刘娟[1,2] 胡春晓[1,2] 钟芮娜 许润春[1] 袁海龙[2]
机构地区:[1]成都中医药大学药学院,四川成都611137 [2]中国人民解放军空军总医院药学部,北京100142 [3]江西中医药大学现代中药制剂教育部重点实验室,江西南昌330004
出 处:《中国中药杂志》2017年第13期2473-2478,共6页China Journal of Chinese Materia Medica
基 金:国家自然科学基金项目(81573697);全军重大科研计划项目[军后综(2016)450]
摘 要:为增加异补骨脂素的皮肤透过量及滞留量,提高其生物利用度。该文采用高压均质法制备异补骨脂素纳米结构脂质载体(IPRN-NLC),以包封率、载药量及平均粒径为评价指标,运用正交实验优化最佳处方。采用Franze扩散池法考察IPRN-NLC的体外透皮。结果表明,最优处方固液脂质比为7∶3,药脂比1∶30,表面活性剂1%,制备的IPRN-NLC平均包封率为(90.25±0.73)%,平均载药量为(1.56±0.27)%,平均粒径为(305±1.57)nm;体外透皮实验显示IPRN-NLC提高了IPRN的皮肤透过量,且皮肤滞留量是IPRN(水)溶液的3倍。采用高压均质法制备的IPRN-NLC提高了IPRN的皮肤透过量及滞留量,在经皮给药领域具有广阔的应用前景。To increase the permeation and retention of isopsoralen in skin, and improve its bioavailability. Isopsoralen loaded nano- structure liquid carrier (IPRN-NLC) was prepared by high pressure homogenization andoptimized by orthogonal experiment with the en- capsulation efficiency, drug loading and average particle size as the evaluation indexes. The in vitro transdermal permeation of IPRN- NLC was evaluated by Franze diffusion cells. The results showed that solid-liquid lipid ratio of optimum IPRN-NLC formulation was 7: 3, drug-lipid ratio of 1 : 30, 1% surfactant. Under these conditions, IPRN-NLC had an average encapsulation of (90. 25 ± 0. 73 ) %, drug loading of ( 1.56 ±0. 27 ) % and an average particle size of ( 305 ±1.57 ) nm. The in vitro transdermal permeation results showed that IPRN-NLC could increase the amount of IPRN permeated though skin, with 3 times of the epidermal retention as compared withIPRN solution. From the results we can know that the IPRN-NLC prepared by high pressure homogenization can improve the permeation andaccumulation of IPRN in the skin, with wide application prospects in the field of transdermnal administration.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.221.158.72